Records containing: P53 Mutation
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-12Canadian Multi-arm Multi-stage Randomized Controlled Trial Assessing Front Line and Maintenance Treatment in Serous or p53 Mutant Endometrial Cancer
-
CLINICAL_TRIALS study record update · 2025-08-07A Phase Ib/II Study of APG-115 as a Monotherapy or in Combination With Pembrolizumab in Patients With Unresectable or Metastatic Melanomas or Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-08-16Decitabine and Arsenic Trioxide(ATO) in the Treatment of Myelodysplasic Syndrome
-
CLINICAL_TRIALS study record update · 2022-11-04Combination of Decitabine and ATO to Treat AML/MDS Expressing a Classified Type of Mutant p53
-
CLINICAL_TRIALS study record update · 2021-06-09Sodium Stibogluconate in the Myelodysplastic Syndromes/Acute Myeloid Leukemia With One of the 65 Defined p53 Mutations That Can be Functionally Rescued by Sodium Stibogluconate
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-01-04Decitabine,Cytarabine(Ara-C) and Arsenic Trioxide(ATO) in the Treatment of Acute Myeloid Leukemia With p53 Mutations